0 Комментарии
0 Поделились
161 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Alpha Thalassemia Market is driven by gene therapy advancementsAlpha thalassemia is a hereditary blood disorder characterized by reduced synthesis of alpha-globin chains, leading to chronic anemia and complications such as splenomegaly and growth retardation. The Alpha Thalassemia Market encompasses a range of products from molecular diagnostics and high-throughput genetic assays to novel therapeutics like gene therapy, transfusion protocols, and iron...0 Комментарии 0 Поделились 64 Просмотры 0 предпросмотр
-
Alpha Thalassemia Market is driven by Therapeutic InnovationsThe Alpha Thalassemia Market encompasses a range of therapeutic products, including gene therapies, RNA interference-based treatments, iron chelation agents, and advanced diagnostic assays. Gene editing approaches aim to correct HBA gene deletions, while RNA-based therapies help modulate globin expression, reducing the need for frequent blood transfusions. Iron chelators prevent excess iron...0 Комментарии 0 Поделились 158 Просмотры 0 предпросмотр